Ligand profile
A
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01352 — Elongation factor Tu
Identifiers
Database identifiers and provenance.
- Ligand ID
A- PDB
4v5g- UniProt (similar protein)
Q5SHN6- Target protein
- KP13_01352
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 186.1
- −1 ≤ LogP ≤ 5 -1.86
- MW ≤ 500 Da 347.2
- LogP ≤ 5 -1.86
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 186.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)Nc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
UDMBCSSLTHHNCD-KQYNXXCUSA-NUDMBCSSLTHHNCD-KQYNXXCUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF03144
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand A →
- PDB RCSB structure 4v5g →
- UniProt UniProt Q5SHN6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “A”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01352.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).